• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 的感染性 cDNA 克隆。

An Infectious cDNA Clone of SARS-CoV-2.

机构信息

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.

出版信息

Cell Host Microbe. 2020 May 13;27(5):841-848.e3. doi: 10.1016/j.chom.2020.04.004. Epub 2020 Apr 13.

DOI:10.1016/j.chom.2020.04.004
PMID:32289263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7153529/
Abstract

The ongoing pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), underscores the urgency to develop experimental systems for studying this virus and identifying countermeasures. We report a reverse genetic system for SARS-CoV-2. Seven complimentary DNA (cDNA) fragments spanning the SARS-CoV-2 genome were assembled into a full-genome cDNA. RNA transcribed from the full-genome cDNA was highly infectious after electroporation into cells, producing 2.9 × 10 plaque-forming unit (PFU)/mL of virus. Compared with a clinical isolate, the infectious-clone-derived SARS-CoV-2 (icSARS-CoV-2) exhibited similar plaque morphology, viral RNA profile, and replication kinetics. Additionally, icSARS-CoV-2 retained engineered molecular markers and did not acquire other mutations. We generated a stable mNeonGreen SARS-CoV-2 (icSARS-CoV-2-mNG) by introducing this reporter gene into ORF7 of the viral genome. icSARS-CoV-2-mNG was successfully used to evaluate the antiviral activities of interferon (IFN). Collectively, the reverse genetic system and reporter virus provide key reagents to study SARS-CoV-2 and develop countermeasures.

摘要

持续的 COVID-19 大流行是由严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)引起的,这突显了开发研究该病毒和确定对策的实验系统的紧迫性。我们报告了一种 SARS-CoV-2 的反向遗传系统。跨越 SARS-CoV-2 基因组的七个互补 DNA(cDNA)片段被组装成全长 cDNA。全长 cDNA 转录的 RNA 在电穿孔进入细胞后具有高度感染性,产生 2.9×10 个噬菌斑形成单位(PFU)/mL 的病毒。与临床分离株相比,传染性克隆衍生的 SARS-CoV-2(icSARS-CoV-2)表现出相似的蚀斑形态、病毒 RNA 谱和复制动力学。此外,icSARS-CoV-2 保留了工程化的分子标记,并且没有获得其他突变。我们通过将该报告基因引入病毒基因组的 ORF7 中,生成了稳定的 mNeonGreen SARS-CoV-2(icSARS-CoV-2-mNG)。icSARS-CoV-2-mNG 成功用于评估干扰素(IFN)的抗病毒活性。总之,该反向遗传系统和报告病毒提供了研究 SARS-CoV-2 和开发对策的关键试剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/139244924c5c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/8f3651b2d46e/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/24c7f315fd98/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/261fcf6e88db/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/33575b4cdbae/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/139244924c5c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/8f3651b2d46e/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/24c7f315fd98/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/261fcf6e88db/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/33575b4cdbae/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71b/7153529/139244924c5c/gr4_lrg.jpg

相似文献

1
An Infectious cDNA Clone of SARS-CoV-2.严重急性呼吸综合征冠状病毒 2 的感染性 cDNA 克隆。
Cell Host Microbe. 2020 May 13;27(5):841-848.e3. doi: 10.1016/j.chom.2020.04.004. Epub 2020 Apr 13.
2
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.从单个细菌人工染色体中拯救 SARS-CoV-2。
mBio. 2020 Sep 25;11(5):e02168-20. doi: 10.1128/mBio.02168-20.
3
Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).广谱基于宿主的抗病毒药物靶向干扰素和脂生成途径,作为大流行冠状病毒病 2019(COVID-19)的潜在治疗选择。
Viruses. 2020 Jun 10;12(6):628. doi: 10.3390/v12060628.
4
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
5
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.快速且允许的病毒 RNA 聚合酶复合物使法匹拉韦迅速掺入,导致 SARS-CoV-2 致命突变。
Nat Commun. 2020 Sep 17;11(1):4682. doi: 10.1038/s41467-020-18463-z.
6
A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.一种符合 BSL-2 标准的 SARS-CoV-2 感染的小鼠模型,用于高效便捷地评估抗病毒药物。
J Virol. 2024 Jul 23;98(7):e0050424. doi: 10.1128/jvi.00504-24. Epub 2024 Jun 20.
7
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.干扰素-β-1a 对病毒感染后给药时体外严重急性呼吸综合征冠状病毒 2 的抑制作用。
J Infect Dis. 2020 Aug 4;222(5):722-725. doi: 10.1093/infdis/jiaa350.
8
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.利用合成基因组学平台快速重建 SARS-CoV-2。
Nature. 2020 Jun;582(7813):561-565. doi: 10.1038/s41586-020-2294-9. Epub 2020 May 4.
9
[A race against the clock: creation of SARS-Cov-2 in the laboratory, a month after its emergence!].[与时间赛跑:新冠病毒在实验室中被制造出来,就在其出现后的一个月!]
Med Sci (Paris). 2020 Aug-Sep;36(8-9):797-802. doi: 10.1051/medsci/2020124. Epub 2020 Aug 5.
10
Antiviral activities of type I interferons to SARS-CoV-2 infection.I 型干扰素对 SARS-CoV-2 感染的抗病毒活性。
Antiviral Res. 2020 Jul;179:104811. doi: 10.1016/j.antiviral.2020.104811. Epub 2020 Apr 29.

引用本文的文献

1
Discovery of thiacyanine dyes as a new class of potent coronavirus inhibitors that suppress viral RNA synthesis.发现硫菁染料作为一类新型强效冠状病毒抑制剂,可抑制病毒RNA合成。
J Biol Chem. 2025 Aug 5;301(9):110547. doi: 10.1016/j.jbc.2025.110547.
2
SARS-CoV-2 Nsp2 recruits GIGYF2 near viral replication sites and supports viral protein production.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白2(Nsp2)在病毒复制位点附近募集GIGYF2,并支持病毒蛋白的产生。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf674.
3
Development of the coronavirus reverse genetic system: Core technology for pathogenesis mechanisms research and vaccine/drug development.

本文引用的文献

1
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.I 型干扰素易感性区分 SARS-CoV-2 和 SARS-CoV。
J Virol. 2020 Nov 9;94(23). doi: 10.1128/JVI.01410-20.
2
Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.在 SARS-CoV-2 的早期进化过程中发现并鉴定了 ORF7b 和 ORF8 中 382 个核苷酸的缺失。
mBio. 2020 Jul 21;11(4):e01610-20. doi: 10.1128/mBio.01610-20.
3
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.
冠状病毒反向遗传系统的发展:发病机制研究及疫苗/药物研发的核心技术
Virulence. 2025 Dec;16(1):2525930. doi: 10.1080/21505594.2025.2525930. Epub 2025 Jun 28.
4
Reverse Genetics-Based Methodology for Molecular Virology Study.基于反向遗传学的分子病毒学研究方法
Methods Mol Biol. 2025;2940:307-318. doi: 10.1007/978-1-0716-4615-1_26.
5
Convergent evolution in nucleocapsid facilitated SARS-CoV-2 adaptation for human infection.核衣壳的趋同进化促进了新冠病毒对人类感染的适应性。
J Virol. 2025 Jul 22;99(7):e0209124. doi: 10.1128/jvi.02091-24. Epub 2025 Jun 12.
6
Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse genetics.利用反向遗传学技术对一组广泛中和性单克隆抗体针对新冠病毒(SARS-CoV-2)新出现变异株的抗性进行测定。
iScience. 2025 Apr 16;28(6):112451. doi: 10.1016/j.isci.2025.112451. eCollection 2025 Jun 20.
7
The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2.弗林蛋白酶切割位点对于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的发病机制是必需的,但对于其传播并非必需。
J Virol. 2025 Jun 10:e0046725. doi: 10.1128/jvi.00467-25.
8
Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk.用于测定母乳中SARS-CoV-2抗体活性的结合与中和试验的开发及一致性
Pathog Immun. 2025 May 22;10(2):97-121. doi: 10.20411/pai.v10i2.799. eCollection 2025.
9
Deletion of the Envelope gene attenuates SARS-CoV-2 infection by altered Spike localization and increased cell-to-cell transmission.包膜基因的缺失通过改变刺突蛋白的定位和增加细胞间传播来减弱新冠病毒感染。
bioRxiv. 2025 May 23:2025.05.20.655126. doi: 10.1101/2025.05.20.655126.
10
Rapid reconstruction of infectious bronchitis virus expressing fluorescent protein from its nsp2 gene based on transformation-associated recombination platform.基于转化相关重组平台从传染性支气管炎病毒的nsp2基因快速构建表达荧光蛋白的病毒
J Virol. 2025 Jul 22;99(7):e0053525. doi: 10.1128/jvi.00535-25. Epub 2025 Jun 5.
利用合成基因组学平台快速重建 SARS-CoV-2。
Nature. 2020 Jun;582(7813):561-565. doi: 10.1038/s41586-020-2294-9. Epub 2020 May 4.
4
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.美国首例冠状病毒病患者感染的严重急性呼吸综合征冠状病毒 2 型。
Emerg Infect Dis. 2020 Jun;26(6):1266-1273. doi: 10.3201/eid2606.200516. Epub 2020 Jun 17.
5
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
6
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.新型冠状病毒 2019-nCoV 的刺突糖蛋白含有弗林蛋白酶样裂解位点,而同一进化枝的 CoV 中则没有。
Antiviral Res. 2020 Apr;176:104742. doi: 10.1016/j.antiviral.2020.104742. Epub 2020 Feb 10.
7
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情,该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
8
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.